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Propofol sedation for endoscopic retrograde cholangiopancreatography (ERCP) procedures is a popular current technique that
has generated controversy in the medical ﬁeld. Worldwide, both anesthetic and nonanesthetic personnel administer this form of
sedation. Although the American and Canadian societies of gastroenterologists have endorsed the administration of propofol by
nonanesthesia personnel, the US Food and Drug Administration (FDA) has not licensed its use in this manner. There is some
evidence for the safe use of propofol by nonanesthetic personnel in patients undergoing endoscopy procedures, but there are
few randomized trials addressing the safety and eﬃcacy of propofol in patients undergoing ERCP procedures. A serious possible
consequence of propofol sedation in patients is that it may result in rapid and unpredictable progression from deep sedation
to general anesthesia, and skilled airway support may be required as a rescue measure. Potential complications following deep
propofol sedation include hypoxemia and hypotension. Propofol sedation for ERCP procedures is an area of clinical practice
where discussion and mutual cooperation between anesthesia and nonanesthesia personnel may enhance patient safety.
1.Introduction
Endoscopic retrograde cholangiopancreatography (ERCP) is
an uncomfortable procedure that requires adequate sedation
or general anaesthesia for successful completion. Currently,
a substantial number of these interventions are performed
worldwide. For instance, over 48,000 procedures are carried
out per annum in the UK alone [1]. With an increasingly
ageingpopulation,thenumberofERCP’sperformedglobally
is likely to increase and with that the demand for adequate
sedation. The procedures are performed under conscious
or deep sedation, and a wide variety of personnel may be
involved in the administration of the sedation. The scope of
this paper is to address some controversial areas regarding
sedation for ERCP’s and to review safety and eﬃcacy aspects
of sedation techniques with special reference to propofol
usage.
2. Controversial Areas
Sedation represents a continuum of states of consciousness
from mild sedation to general anaesthesia. The ASA has
deﬁned several levels of sedation from minimal through
moderate sedation (conscious) to deep sedation after which
general anaesthesia ensues [2]. Most cases of ERCP are per-
formed either under conscious sedation, using midazolam
with opioid (commonly Demerol) or deep sedation using
propofol. Internationally, nonanesthesia use of propofol is
in widespread use for endoscopies, and an impressive track
record of its safety for these procedures has been built up.
Almost half a million cases have been reported with a low
incidence of problems [3]. Further support for the use of
propofol by nonanesthesia personnel has come from the
American and Canadian society of gastroenterologists, who
have endorsed its use by these personnel [4, 5].
However, the administration of propofol by nonanesthe-
sia personnel forsedation, althoughpopular, is a contentious
issue. In 2005, the American society of gastroenterologists
petitioned the FDA to remove the requirement that “for
general anaesthesia or monitored anesthesia care (MAC)
sedation, Diprivan injectable emulsion should be admin-
istered only by persons trained in the administration of
general anesthesia and not involved in the conduct of the2 Diagnostic and Therapeutic Endoscopy
surgical/diagnostic procedure.” However, this petition was
ultimately denied in 2010 [6]. The consequences of this rul-
ing will become evident in the future.
In countries such as the UK, gastroenterologists com-
monly perform ERCP under conscious sedation. However,
both the Royal College of Anaesthetists (UK) and the
AmericanSocietyofAnesthesiologistsconsiderthatpropofol
sedation should ideally be administered by anesthesia per-
sonnel [7, 8].
Deep propofol sedation for patients undergoing ERCP
procedures is preferred to conscious sedation by gastroen-
terologists at our institution, as they feel that patients often
tolerate the procedure better. There appears to be some
evidence to support this view [9, 10]. Laurie et al. in a retro-
spective chart review compared anaesthesia related sedation
to conscious sedation for 732 ERCP procedures [9]. 17
patients failed to complete the procedure due to inadequate
sedation in the conscious sedation group versus 3 patients
in the anaesthesia related group. In addition, they found that
thesuccessrateofERCPwashigherintheanaesthesiarelated
group (8.2% failure versus 19.2%) [9]. Penston prospectively
reviewed 1550 ERCP procedures performed mainly under
conscioussedation.Hefoundthatpatientcooperationunder
conscious sedation (with Midazolam and Demerol) was not
ideal in a signiﬁcant number of patients, and this lack of
cooperation made the performance of the procedure more
diﬃcult [10]. Our experience shows that approximately 9%
of patients presenting for ERCP under propofol sedation
are referred because the procedure could not be performed
under conscious sedation.
An important consideration regarding sedation is that
althoughlevelsofsedationhavebeendeﬁned,theactuallevel
of sedation in patients may easily ﬂuctuate, depending on
the amount of drug used and sensitivity of the patient. For
instance, a signiﬁcant number of patients under conscious
sedation may progress unintended to a level of deep sedation
[11]. Deep sedation, as deﬁned by the ASA, can require
airway intervention, and spontaneous ventilation may be
inadequate to maintain oxygenation and gas exchange.
Propofol has a narrow therapeutic window, and a small
increase in dosage may cause a patient to progress from deep
sedation to a state of general anesthesia. This is an important
reason why some authorities such as the Royal College of
Anaesthetists in the UK maintain that patients undergoing
deep sedation require the same level of care as those under
general anesthesia [7]. This represents a further area of
controversy, which is the use of deep sedation (inadvertent
or deliberate) by nonanesthetic personnel.
3. Safety of ERCP underSedation
Signiﬁcant complications such as hypoxemia, hypotension,
and aspiration are potential risks in patients undergoing
ERCP procedures, and important factors that can modify
the severity of these events include patients’ ASA status,
patients’ hydration and oxygenation status, and monitoring
techniques used during the procedure.
The majority of ERCP’s are done under sedation with
an open airway. Interestingly, aspiration has not often been
reported as a problem, as patients are usually fasted and have
empty stomachs. In our experience, small amounts of regur-
gitation with no signiﬁcant sequelae are not uncommon in
these patients. However, prolonged or diﬃcult procedures
may be associated with increased risks of regurgitation and
aspiration, and this has been highlighted in a bulletin from
the New Zealand College of Anaesthetists [12].
Two UK authorities, NCEPOD, and the British Society of
Gastroenterologists have reviewed the safety of performing
ERCP under conscious sedation [1, 13]. The 2004 ret-
rospective review done by NCEPOD entitled “scoping your
practice” identiﬁed a critical incident rate of 9% in patients
undergoing ERCP procedures under conscious sedation and
quoted a mortality rate of 2%. However, there were a rel-
atively small number of patients reviewed, and the authors
acknowledged that there may have been signiﬁcant underre-
porting ofsomeofthecomplicationsduetotheretrospective
nature of the survey. It was signiﬁcant that many of the
procedures done were considered to be inappropriate and
that 77% of patients were ASA 3 and above. The survey
performed by the BSG in 2005 included a larger group
of patients and identiﬁed a procedure-related mortality of
0.4% (signiﬁcantly less than reported by the NCEPOD
report). Patients were also more appropriately selected for
procedures, with only 12.7% being above ASA 3.
Deenadayalu et al. conducted a worldwide safety review
onpatientsundergoingendoscopicproceduresunderpropo-
fol sedation and found 3 deaths in 456,918 procedures [3].
However, the number of patients undergoing deep sedation
is unclear.
Linder et al. [14] analyzed 2113 ERCP cases performed
under nurse administered midazolam and narcotic sedation
or anaesthesia personnel administered deep propofol seda-
tion.Therewasalowcomplicationrate.Therewasonedeath,
less than 1% of cases had to be converted to general an-
aesthesia, and approximately 6% of cases were deemed to
require general anaesthesia electively for the procedures.
Cot´ e et al. [15] prospectively studied 799 cases of
patients undergoing endoscopy (ERCP, EUS, and small
bowel enteroscopy) procedures under propofol sedation and
found a hypoxemia rate of 12.8% and a hypotension rate
of 0.8% during the procedure. There was a premature
termination rate of 0.6%. Over 60% of patients had an ASA
of3orabove.Airwaymaneuverswererequiredin14.4%,and
ASA status 3 or higher and increased BMI were independent
predictors of the need for airway intervention.
Only a limited number of randomized trials have
addressed the issue of sedation for ERCP procedures. Four
of these compared conscious sedation with midazolam and
Demerol to propofol sedation [16–19]. In all of these trials,
nonanesthesia personnel were involved in administrating the
sedation.TwoofthetrialsinvolvedASA1–3patients[17,19],
whilst the other two also included ASA 4 patients [16, 18].
There was no immediate mortality in any of the techniques.
In one study 5 patients had to have the procedure terminated
because of sedation-related problems [19], but in the other
three trials, sedation seems to have been successful in all
patients irrespective of the type of sedation used. None of
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such as hypoxemia and hypotension (systolic < 90mm
Hg) between the two sedation techniques. However, two
papers appear not to have administered oxygen during the
procedure and report relatively high incidences of hypoxia
using both techniques of sedation [17, 19].
4.PracticalAspects
Results from the limited number of studies performed
comparing propofol sedation with conscious sedation for
ERCP procedures have deﬁnitively indicated that patients
w h oh a v er e c e i v e dp r o p o f o lf o rt h ep r o c e d u r eh a v eab e t t e r
recovery proﬁle [16, 17].
Patients presenting for ERCP may often be elderly and
inﬁrm, and a signiﬁcant proportion of them will be in the
ASA 3 and 4 categories. Cardiorespiratory complications
may occur more frequently, and the elderly may have de-
pressed airway reﬂexes, making them more prone to aspi-
ration. Common sense would suggest that in this group of
patients extra care is taken to ensure adequate hydration
and oxygenation before the procedure commences. Cot´ ee t
al. [15] have conﬁrmed that patients with an ASA category
of 3 or higher required signiﬁcantly more additional airway




The Royal College of Anaesthetists (UK) in conjunction with
the British Society of Gastroenterology has issued guidance
for patients undergoing propofol sedation for procedures
such as ERCP [7]. The American Society of Anesthesiologists
has also issued a guidance statement for the safe use of
propofol in the context of sedation [8]. The specialist bodies’
opinion is that propofol sedation requires speciﬁc training
and skills for the following reasons.
(i) Propofol has potential to cause rapid and profound
changes in sedative/anesthetic depth.
(ii) Propofol has no speciﬁc antagonists.
(iii) Propofol can have marked synergy with other drugs.
The guidance addresses the issues of personnel admin-
istering the sedation, patient selection, equipment and
monitoring, staﬃng levels, and generic training. Brieﬂy,
the recommendation is that propofol sedation is ideally
administered by dedicated and appropriately trained anes-
thesia personnel, but where this is not possible, dedicated
and appropriately trained nonanesthesia personnel can take
on this role, provided certain conditions are met. Patients
should be adequately screened as to their suitability for this
form of sedation as certain groups of patients (e.g., those
with morbid obesity or severe cardiac or respiratory disease)
are more at risk of developing complications during the
sedation. For these group of patients, full general anesthesia
with controlled ventilation should be planned. There should
be a minimum level of cardiorespiratory monitoring used
in patients undergoing propofol sedation, and this should
include pulse oximetry and continuous capnography in
additiontoEKGandnoninvasivebloodpressure.Allpatients
should receive continuous oxygen from the start of the
procedure till the recovery period.
6. Propofol Sedation Experience at
St. George’s Hospital, UK
At our institution, propofol sedation for ERCP procedures
is administered by consultant anesthesiologists (referred to
as anaesthetists in UK). We follow a standard protocol
for the administration of propofol, and all patients receive
supplemental oxygen during the procedure. We monitor
noninvasive blood pressure, EKG, end tidal carbon dioxide
(ETCO2), and pulse oximeter oxygen saturation during
the procedure as recommended by the Royal College of
AnaesthetistsandAmericanSocietyofAnesthesiologists.The
ETCO2 monitoring is facilitated by means of a modiﬁed
mouthguard (manufactured by Pennine), which is capable
of simultaneously delivering oxygen and sampling carbon
dioxide from the patient, whilst facilitating the insertion of
the endoscope [20]. The capnograph trace from this device
is highly reliable, and we ﬁnd it invaluable for maintaining
the appropriate sedation level of the patient and detecting
respiratory depression or obstruction. Qadeer et al. have
demonstrated that the rate of hypoxemia can be reduced
duringERCPproceduresbyincorporatingcapnographmon-
itoring [21].
Our experience with this technique in approximately 150
ASA1-3 patients undergoing ERCP with propofol sedation
suggeststhatalowcomplicationratecanbeachieved.Results
ofourasyetunpublishedprospectiveauditdatademonstrate
a transient hypoxemia rate of approximately 2%, and a
transient hypotension rate (<90mm Hg) of 5%. Sedation
was successful in all patients. 9% of patients presenting for
the ERCP procedure under propofol sedation had previously
not tolerated the procedure under conscious sedation. 2
(1.3%) patients received elective intubation with general
anesthesia for the ERCP procedure. Our indications for intu-
bation include obesity, severe respiratory disease, anticipated
prolonged procedure, and history of severe regurgitation. No
patients had to be intubated as an emergency.
7. Development of Proﬁciency in Propofol
Sedationfor Nonanesthesia Personnel
We recommend following the guidance provided by the
Royal College of Anaesthetists and American Society of
Anesthesiologists regarding use of propofol for sedation. We
also recognize that it may not be feasible for anesthesia
personnel to administer propofol sedation for patients
undergoing ERCP procedures in many instances. In these
situations, we believe that it is acceptable for nonanesthesia
personnel to administer propofol to patients undergoing
ERCP procedures, provided that they have been adequately
trained and certain conditions are met. A suggested training
curriculum for nonanesthesia personnel wanting to learn the4 Diagnostic and Therapeutic Endoscopy
technique of propofol sedation has been comprehensively
covered by major American gastroenterology bodies under
the components of didactic training, airway workshops, sim-
ulation training, and preceptorship [4], and we concur with
these. These conditions we suggest are outlined below.
(i) The practitioner should be a dedicated and appropri-
ately trained person, with adequate life support and
airway rescue skills.
(ii) He/she should be regularly involved in administra-
tion of propofol sedation for a suﬃcient number of
patients undergoing ERCP procedures.
(iii) A period of preceptorship with an anesthesiologist
e x p e r i e n c e di np r o p o f o ls e d a t i o nf o re n d o s c o p y
procedures should be a core part of training.
(iv) Preceptorship should be part of an ongoing process,
with regular updates and refresher sessions.
(v) Patients should be screened for suitability, and not
have any risk factors suggesting development of com-
plications under deep sedation (e.g., obesity, se-
vere cardiorespiratory disease, and severe gas-
troesophageal reﬂux).
(vi) The procedure should not anticipated to be unduly
diﬃcult or prolonged.
(vii) The procedures should be performed in a center
where immediate anesthesiology assistance is avail-
able.
(viii) Recommended monitoring, including capnography
should be performed on all patients.
We consider that there is a learning curve involved with
acquiring the subset of technical and decision-making skills
necessary to become proﬁcient at administering propofol
for sedation. In our opinion, these are best learnt over a
period of time under the supervision of an anesthesiologist
experiencedinthisﬁeld.Inthiscontext,itmightbebeneﬁcial
to consider use of Bispectral index monitoring (BIS) early
on in the preceptorship, as this might facilitate objective
assessment of level of sedation during the procedure [22].
The practitioner may also want to incorporate this into
his/her practice after the period of training. We suggest that
adequate proﬁciency could be achieved after administration
of propofol for 100 patients requiring ERCP (under super-
vision) although we accept that this number is open to
discussion. Some of the skills that we feel are important to
acquire are listed below:
(i) familiarity with administration of protocol following
a set protocol,
(ii) recognition and treatment of common problems
such as respiratory obstruction,
(iii) deciding which patients would be best suited for
elective full general anesthesia,
(iv) anticipating when to abort the procedure so as to
prevent escalation of complications,
(v) anticipating when to call for assistance from anesthe-
siology.
8. Cost Issues
There is no doubt that patients undergoing ERCP pro-
cedures under propofol sedation have a much improved
recovery proﬁle (both immediately and at 24 hours) than
patients who have undergone the procedure under midazo-
lam/meperidine conscious sedation [17]. The big question
is who administers the sedation? If anesthesia personnel do
so, then the cost of the procedure increases signiﬁcantly, and
gastroenterologysocietiesandhealthinsurancecompaniesin
the USA have taken the position that this is only warranted
in high-risk patients [23]. Nurse administered propofol
sedation is an alternative that would be cost eﬀective but is
one that may be opposed by anesthesiologists unless there is
appropriate supervision and support. It also may not be a
global solution, as legislative considerations may enter into
the decision, depending on the country concerned.
9. Conclusion
Sedation for ERCP procedures is a challenging area for
clinicians, where there is an overlap between anesthetic
and nonanesthetic practice. Propofol can be administered
relatively safely for endoscopic procedures by nonanes-
thetic personnel [3]. However, it is diﬃcult to envisage
a future without signiﬁcant anesthesiology involvement in
this controversial area. Cooperation and discussion between
gastroenterologistsandanesthesiologistsmaypavethewayto
a realizable solution. The ﬁnal outcome will undoubtedly be
determined by a mixture of ﬁnancial, political, and scientiﬁc
debate and may well diﬀer internationally.
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